Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis

References

• Fidler IJ. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer. 2003; 3: 453–8. [PubMed Abstract].
   Google Scholar
• Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, Gould SJ. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol. 2006; 172: 923–35. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Inal JM, Ansa-Addo EA, Stratton D, Kholia S, Antwi-Baffour SS, Jorfi S et al. Microvesicles in health and disease. Arch Immunol Ther Exp (Warsz). 2012; 60: 107–21. [PubMed Abstract].
   Google Scholar
• Record M, Subra C, Silvente-Poirot S, Poirot M. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol. 2011; 81: 1171–82. [PubMed Abstract].
   Google Scholar
• Saunderson SC, Schuberth PC, Dunn AC, Miller L, Hock BD, MacKay PA et al. Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor. J Immunol. 2008; 180: 8146–52. [PubMed Abstract].
   Google Scholar
• Faure J, Lachenal G, Court M, Hirrlinger J, Chatellard-Causse C, Blot B et al. Exosomes are released by cultured cortical neurones. Mol Cell Neurosci. 2006; 31: 642–8. [PubMed Abstract].
   Google Scholar
• Hsu C, Morohashi Y, Yoshimura S, Manrique-Hoyos N, Jung S, Lauterbach MA et al. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol. 2010; 189: 223–32. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010; 12: 19–30; sup pp. 1–13. [PubMed Abstract].
   Google Scholar
• Rana S, Zoller M. Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis. Biochem Soc Trans. 2011; 39: 559–62. [PubMed Abstract].
   Google Scholar
• Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009; 19: 43–51. [PubMed Abstract].
   Google Scholar
• Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012; 1820: 940–8. [PubMed Abstract].
   Google Scholar
• Szajnik M, Derbis M, Lach M, Patalas P, Michalak M, Drzewiecka H. Exosomes in plasma of patients with ovarian carcinoma: potential biomarkers of tumor progression and response to therapy. Gynecol Obstet (Sunnyvale). 2013 Suppl 4 3.
   Google Scholar
• Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer. 2003; 39: 184–91. [PubMed Abstract].
   Google Scholar
• Baran J, Baj-Krzyworzeka M, Weglarczyk K, Szatanek R, Zembala M, Barbasz J et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother. 2010; 59: 841–50. [PubMed Abstract].
   Google Scholar
• Gao Q, Zhao YJ, Wang XY, Guo WJ, Gao S, Wei L et al. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients. Gastroenterology. 2014; 146: 1397–407. [PubMed Abstract].
   Google Scholar
• Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. 2014; 26: 707–21. [PubMed Abstract].
   Google Scholar
• Lee TH, Chennakrishnaiah S, Audemard E, Montermini L, Meehan B, Rak J. Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells. Biochem Biophys Res Commun. 2014; 451: 295–301. [PubMed Abstract].
   Google Scholar
• Abd Elmageed ZY, Yang Y, Thomas R, Ranjan M, Mondal D, Moroz K et al. Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes. Stem Cells. 2014; 32: 983–97. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Matsuoka J, Yashiro M, Doi Y, Fuyuhiro Y, Kato Y, Shinto O et al. Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFbeta signaling. PLoS One. 2013; 8: e62310. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Tauro BJ, Mathias RA, Greening DW, Gopal SK, Ji H, Kapp EA et al. Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial–mesenchymal transition. Mol Cell Proteomics. 2013; 12: 2148–59. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 654–9. [PubMed Abstract].
   Google Scholar
• Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013; 32: 623–42. [PubMed Abstract].
   Google Scholar
• Josson S, Gururajan M, Sung SY, Hu P, Shao C, Zhau HE et al. Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis. Oncogene. 2014; 34: 2690–9. [PubMed Abstract].
   Google Scholar
• Bravo-Cordero JJ, Hodgson L, Condeelis J. Directed cell invasion and migration during metastasis. Curr Opin Cell Biol. 2012; 24: 277–83. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ramteke A, Ting H, Agarwal C, Mateen S, Somasagara R, Hussain A. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules. Mol Carcinog. 2013 doi: 10.1002/mc.22124. [Epub ahead of print].
   Web of Science ®Google Scholar
• Lin R, Wang S, Zhao RC. Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model. Mol Cell Biochem. 2013; 383: 13–20. [PubMed Abstract].
   Google Scholar
• Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 2012; 151: 1542–56. [PubMed Abstract].
   Google Scholar
• Bijnsdorp IV, Geldof AA, Lavaei M, Piersma SR, van Moorselaar RJ, Jimenez CR. Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. J Extracell Vesicles. 2013; 2 [PubMed CentralFull Text].
   Google Scholar
• Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 2003; 3: 362–74. [PubMed Abstract].
   Google Scholar
• Kriebel PW, Barr VA, Rericha EC, Zhang G, Parent CA. Collective cell migration requires vesicular trafficking for chemoattractant delivery at the trailing edge. J Cell Biol. 2008; 183: 949–61. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Wong AD, Searson PC. Live-cell imaging of invasion and intravasation in an artificial microvessel platform. Cancer Res. 2014; 74: 4937–45. [PubMed Abstract].
   Google Scholar
• Wyckoff JB, Wang Y, Lin EY, Li JF, Goswami S, Stanley ER et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 2007; 67: 2649–56. [PubMed Abstract].
   Google Scholar
• Bretz NP, Ridinger J, Rupp AK, Rimbach K, Keller S, Rupp C et al. Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling. J Biol Chem. 2013; 288: 36691–702. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Soki FN, Koh AJ, Jones JD, Kim YW, Dai J, Keller ET et al. Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis. J Biol Chem. 2014; 289: 24560–72. [PubMed Abstract].
   Google Scholar
• Taraboletti G, D'Ascenzo S, Giusti I, Marchetti D, Borsotti P, Millimaggi D et al. Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia. 2006; 8: 96–103. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Taverna S, Flugy A, Saieva L, Kohn EC, Santoro A, Meraviglia S et al. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis. Int J Cancer. 2012; 130: 2033–43. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Chen T, Guo J, Yang M, Zhu X, Cao X. Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine. J Immunol. 2011; 186: 2219–28. [PubMed Abstract].
   Google Scholar
• Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008; 27: 2128–36. [PubMed Abstract].
   Google Scholar
• Wang J, Zhou Y, Lu J, Sun Y, Xiao H, Liu M et al. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma. Med Oncol. 2014; 31: 148. [PubMed Abstract].
   Google Scholar
• Wang H, Hou L, Li A, Duan Y, Gao H, Song X. Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma. Biomed Res Int. 2014; 2014: 864894. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Corcoran C, Friel AM, Duffy MJ, Crown J, O'Driscoll L. Intracellular and extracellular microRNAs in breast cancer. Clin Chem. 2011; 57: 18–32. [PubMed Abstract].
   Google Scholar
• Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014; 25: 501–15. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Egan K, Crowley D, Smyth P, O'Toole S, Spillane C, Martin C et al. Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS One. 2011; 6: e26125. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer. 2005; 113: 752–60. [PubMed Abstract].
   Google Scholar
• Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett. 2012; 315: 28–37. [PubMed Abstract].
   Google Scholar
• Hedlund M, Nagaeva O, Kargl D, Baranov V, Mincheva-Nilsson L. Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS One. 2011; 6: e16899. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Whiteside TL. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem Soc Trans. 2013; 41: 245–51. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Cereghetti DM, Lee PP. Tumor-derived exosomes contain microRNAs with immunological function: implications for a novel immunosuppression mechanism. Microrna. 2014; 2: 194–204. [PubMed Abstract].
   Google Scholar
• Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One. 2010; 5: e11469. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Filipazzi P, Burdek M, Villa A, Rivoltini L, Huber V. Recent advances on the role of tumor exosomes in immunosuppression and disease progression. Semin Cancer Biol. 2012; 22: 342–9. [PubMed Abstract].
   Google Scholar
• Miles FL, Pruitt FL, van Golen KL, Cooper CR. Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis. 2008; 25: 305–24. [PubMed Abstract].
   Google Scholar
• Hiratsuka S, Goel S, Kamoun WS, Maru Y, Fukumura D, Duda DG et al. Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation. Proc Natl Acad Sci U S A. 2011; 108: 3725–30. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS Jr, Gimbrone MA. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A. 1987; 84: 9238–42. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Soderberg A, Barral AM, Soderstrom M, Sander B, Rosen A. Redox-signaling transmitted in trans to neighboring cells by melanoma-derived TNF-containing exosomes. Free Radic Biol Med. 2007; 43: 90–9. [PubMed Abstract].
   Google Scholar
• Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A. 2009; 106: 3794–9. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Herlaar E, Brown Z. p38 MAPK signalling cascades in inflammatory disease. Mol Med Today. 1999; 5: 439–47. [PubMed Abstract].
   Google Scholar
• Reymond N, Im JH, Garg R, Vega FM, Borda dAB, Riou P et al. Cdc42 promotes transendothelial migration of cancer cells through beta1 integrin. J Cell Biol. 2012; 199: 653–68. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Barthel SR, Hays DL, Yazawa EM, Opperman M, Walley KC, Nimrichter L et al. Definition of molecular determinants of prostate cancer cell bone extravasation. Cancer Res. 2013; 73: 942–52. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Brandt B, Heyder C, Gloria-Maercker E, Hatzmann W, Rotger A, Kemming D et al. 3D-extravasation model – selection of highly motile and metastatic cancer cells. Semin Cancer Biol. 2005; 15: 387–95. [PubMed Abstract].
   Google Scholar
• Gambim MH, do CAO, Marti L, Verissimo-Filho S, Lopes LR, Janiszewski M. Platelet-derived exosomes induce EC apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction. Crit Care. 2007; 11: R107. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Reymond N, d'Agua BB, Ridley AJ. Crossing the endothelial barrier during metastasis. Nat Rev Cancer. 2013; 13: 858–70. [PubMed Abstract].
   Google Scholar
• Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer. 2009; 9: 285–93. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Kaplan RN, Rafii S, Lyden D. Preparing the “soil”: the premetastatic niche. Cancer Res. 2006; 66: 11089–93. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Castellana D, Zobairi F, Martinez MC, Panaro MA, Mitolo V, Freyssinet JM et al. Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res. 2009; 69: 785–93. [PubMed Abstract].
   Google Scholar
• Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005; 438: 820–7. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Jung T, Castellana D, Klingbeil P, Cuesta HI, Vitacolonna M, Orlicky DJ et al. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia. 2009; 11: 1093–105. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Rana S, Malinowska K, Zoller M. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia. 2013; 15: 281–95. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012; 18: 883–91. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ono M, Kosaka N, Tominaga N, Yoshioka Y, Takeshita F, Takahashi RU et al. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal. 2014; 7: ra63. [PubMed Abstract].
   Google Scholar
• Altevogt P, Bretz NP, Ridinger J, Utikal J, Umansky V. Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation. Semin Cancer Biol. 2014; 28: 51–7. [PubMed Abstract].
   Google Scholar
• Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A. 2012; 109: E2110–16. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Clayton A, Tabi Z. Exosomes and the MICA-NKG2D system in cancer. Blood Cells Mol Dis. 2005; 34: 206–13. [PubMed Abstract].
   Google Scholar
• Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 2007; 67: 7458–66. [PubMed Abstract].
   Google Scholar
• Yang C, Kim SH, Bianco NR, Robbins PD. Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. PLoS One. 2011; 6: e22517. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res. 1996; 56: 5754–7. [PubMed Abstract].
   Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140: 883–99. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• King HW, Michael MZ, Gleadle JM. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 2012; 12: 421. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002; 29(Suppl 16): 15–18. [PubMed Abstract].
   Google Scholar
• Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature. 1990; 348: 555–7. [PubMed Abstract].
   Google Scholar
• Vader P, Breakefield XO, Wood MJ. Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med. 2014; 20: 385–93. [PubMed Abstract].
   Google Scholar
• Hood JL, San RS, Wickline SA. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 2011; 71: 3792–801. [PubMed Abstract].
   Google Scholar
• Nazarenko I, Rana S, Baumann A, McAlear J, Hellwig A, Trendelenburg M et al. Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res. 2010; 70: 1668–78. [PubMed Abstract].
   Google Scholar
• Jain KK. Personalized medicine: the impact of pharmacogenetics on drug development. 1998; Waltham, MA: Decision Resources. v, 44 leaves p.
   Google Scholar
• Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012; 366: 883–92. [PubMed Abstract].
   Google Scholar
• Ginestra A, La Placa MD, Saladino F, Cassara D, Nagase H, Vittorelli ML. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res. 1998; 18: 3433–7. [PubMed Abstract].
   Google Scholar
• Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 2009; 100: 1603–7. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012; 64: 676–705. [PubMed Abstract].
   Google Scholar
• Mizutani K, Terazawa R, Kameyama K, Kato T, Horie K, Tsuchiya T et al. Isolation of prostate cancer-related exosomes. Anticancer Res. 2014; 34: 3419–23. [PubMed Abstract].
   Google Scholar
• Mitchell PJ, Welton J, Staffurth J, Court J, Mason MD, Tabi Z et al. Can urinary exosomes act as treatment response markers in prostate cancer?. J Transl Med. 2009; 7: 4. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Que R, Ding G, Chen J, Cao L. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World J Surg Oncol. 2013; 11: 219. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Yamashita T, Kamada H, Kanasaki S, Maeda Y, Nagano K, Abe Y et al. Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis. Pharmazie. 2013; 68: 969–73. [PubMed Abstract].
   Google Scholar
• Kahlert C, Melo SA, Protopopov A, Tang J, Seth S, Koch M et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem. 2014; 289: 3869–75. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Khan S, Jutzy JM, Valenzuela MM, Turay D, Aspe JR, Ashok A et al. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS One. 2012; 7: e46737. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Lu Q, Zhang J, Allison R, Gay H, Yang WX, Bhowmick NA et al. Identification of extracellular delta-catenin accumulation for prostate cancer detection. Prostate. 2009; 69: 411–18. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Bryant RJ, Pawlowski T, Catto JW, Marsden G, Vessella RL, Rhees B et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer. 2012; 106: 768–74. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008; 105: 10513–18. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Lodes MJ, Caraballo M, Suciu D, Munro S, Kumar A, Anderson B. Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One. 2009; 4: e6229. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Helley D, Banu E, Bouziane A, Banu A, Scotte F, Fischer AM et al. Platelet microparticles: a potential predictive factorof survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol. 2009; 56: 479–84. [PubMed Abstract].
   Google Scholar
• Tavoosidana G, Ronquist G, Darmanis S, Yan J, Carlsson L, Wu D et al. Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer. Proc Natl Acad Sci U S A. 2011; 108: 8809–14. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer. 2009; 9: 244. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Keller S, Konig AK, Marme F, Runz S, Wolterink S, Koensgen D et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. Cancer Lett. 2009; 278: 73–81. [PubMed Abstract].
   Google Scholar
• Runz S, Keller S, Rupp C, Stoeck A, Issa Y, Koensgen D et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol. 2007; 107: 563–71. [PubMed Abstract].
   Google Scholar
• Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 2004; 64: 7045–9. [PubMed Abstract].
   Google Scholar
• Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008; 110: 13–21. [PubMed Abstract].
   Google Scholar
• Li Y, Zhang Y, Qiu F, Qiu Z. Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. Electrophoresis. 2011; 32: 1976–83. [PubMed Abstract].
   Google Scholar
• Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol. 2004; 31: 114–21. [PubMed Abstract].
   Google Scholar
• Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol. 2010; 28: 1721–6. [PubMed Abstract].
   Google Scholar
• Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, Rom WN et al. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol. 2013; 8: 1156–62. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Rodriguez M, Silva J, Lopez-Alfonso A, Lopez-Muniz MB, Pena C, Dominguez G et al. Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer. Genes Chromosomes Cancer. 2014; 53: 713–24. [PubMed Abstract].
   Google Scholar
• Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009; 10: 42–6. [PubMed Abstract].
   Google Scholar
• Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS et al. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med. 2012; 18: 1835–40. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10: 1470–6. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Mao X, Sun Y, Tang J. Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma. Neurol Sci. 2014; 35: 233–8. [PubMed Abstract].
   Google Scholar
• Manterola L, Guruceaga E, Gallego P-LJ, Gonzalez-Huarriz M, Jauregui P, Tejada S et al. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro-Oncology. 2014; 16: 520–7. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Akers JC, Ramakrishnan V, Kim R, Skog J, Nakano I, Pingle S et al. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS One. 2013; 8: e78115. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D et al. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One. 2010; 5: 13515.
   PubMed Web of Science ®Google Scholar
• Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M et al. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage. Gynecol Oncol. 2011; 122: 437–46. [PubMed Abstract].
   Google Scholar
• Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M et al. Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol. 2012; 227: 658–67. [PubMed Abstract].
   Google Scholar
• Arscott WT, Camphausen KA. EGFR isoforms in exosomes as a novel method for biomarker discovery in pancreatic cancer. Biomark Med. 2011; 5: 821. [PubMed Abstract].
   Google Scholar
• Lau C, Kim Y, Chia D, Spielmann N, Eibl G, Elashoff D et al. Role of pancreatic cancer-derived exosomes in salivary biomarker development. J Biol Chem. 2013; 288: 26888–97. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Choi DS, Park JO, Jang SC, Yoon YJ, Jung JW, Choi DY et al. Proteomic analysis of microvesicles derived from human colorectal cancer ascites. Proteomics. 2011; 11: 2745–51. [PubMed Abstract].
   Google Scholar
• Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K et al. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014; 9: e92921. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Silva J, Garcia V, Rodriguez M, Compte M, Cisneros E, Veguillas P et al. Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer. 2012; 51: 409–18. [PubMed Abstract].
   Google Scholar
• Logozzi M, De Milito A, Lugini L, Borghi M, Calabro L, Spada M et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 2009; 4: e5219. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Smalley DM, Sheman NE, Nelson K, Theodorescu D. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J Proteome Res. 2008; 7: 2088–96. [PubMed Abstract].
   Google Scholar
• Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost. 2007; 5: 520–7. [PubMed Abstract].
   Google Scholar
• Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M et al. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer. 2013; 119: 1159–67. [PubMed Abstract].
   Google Scholar
• Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One. 2009; 4: e5532. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Wang W, Li H, Zhou Y, Jie S. Peripheral blood microvesicles are potential biomarkers for hepatocellular carcinoma. Cancer Biomark. 2013; 13: 351–7. [PubMed Abstract].
   Google Scholar
• Aushev VN, Zborovskaya IB, Laktionov KK, Girard N, Cros MP, Herceg Z et al. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma. PLoS One. 2013; 8: e78649. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Fleitas T, Martínez-Sales V, Vila V, Reganon E, Mesado D, Martín M et al. Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer. PLoS One. 2012; 7: e47365. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Younus S, Rodgers G. Biomarkers associated with cardiometabolic risk in obesity. Am Heart Hosp J. 2011; 9: E28–32. [PubMed Abstract].
   Google Scholar
• Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014; 24: 766–9. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Taylor DD, Zacharias W, Gercel-Taylor C. Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol. 2011; 728: 235–46. [PubMed Abstract].
   Google Scholar
• Rekker K, Saare M, Roost AM, Kubo AL, Zarovni N, Chiesi A et al. Comparison of serum exosome isolation methods for microRNA profiling. Clin Biochem. 2014; 47: 135–8. [PubMed Abstract].
   Google Scholar
• Alvarez ML, Khosroheidari M, Kanchi Ravi R, DiStefano JK. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int. 2012; 82: 1024–32. [PubMed Abstract].
   Google Scholar
• Chen WW, Balaj L, Liau LM, Samuels ML, Kotsopoulos SK, Maguire CA et al. BEAMing and droplet digital PCR analysis of mutant IDH1 mRNA in glioma patient serum and cerebrospinal fluid extracellular vesicles. Mol Ther Nucleic Acids. 2013; 2: e109. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Jenjaroenpun P, Kremenska Y, Nair VM, Kremenskoy M, Joseph B, Kurochkin IV. Characterization of RNA in exosomes secreted by human breast cancer cell lines using next-generation sequencing. PeerJ. 2013; 1: e201. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Orozco AF, Lewis DE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A. 2010; 77: 502–14. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Jorgensen M, Baek R, Pedersen S, Sondergaard EK, Kristensen SR, Varming K. Extracellular Vesicle (EV) Array: microarray capturing of exosomes and other extracellular vesicles for multiplexed phenotyping. J Extracell Vesicles. 2013; 2
   Google Scholar
• Shao H, Min C, Issadore D, Liong M, Yoon TJ, Weissleder R et al. Magnetic nanoparticles and microNMR for diagnostic applications. Theranostics. 2012; 2: 55–65. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol. 2014; 32: 490–5. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Yoshioka Y, Kosaka N, Konishi Y, Ohta H, Okamoto H, Sonoda H et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Commun. 2014; 5: 3591. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Inal JM, Kosgodage U, Azam S, Stratton D, Antwi-Baffour S, Lange S. Blood/plasma secretome and microvesicles. Biochim Biophys Acta. 2013; 1834: 2317–25. [PubMed Abstract].
   Google Scholar
• Chargaff E, West R. The biological significance of the thromboplastic protein of blood. J Biol Chem. 1946; 166: 189–97. [PubMed Abstract].
   Google Scholar
• Huang X, Yuan T, Tschannen M, Sun Z, Jacob H, Du M et al. Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics. 2013; 14: 319. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012; 10: e1001450. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar